SUCCINYLCHOLINE CHLORIDE
PeakNDAINTRAMUSCULAR, INTRAVENOUSSOLUTION
Approved
Aug 2021
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Succinylcholine chloride is a depolarizing neuromuscular blocking agent administered intravenously or intramuscularly to induce rapid flaccid paralysis for mechanical ventilation and anesthesia support. It works by mimicking acetylcholine at the motor end plate, causing depolarization and subsequent inhibition of neuromuscular transmission. Onset is rapid (under one minute) with duration of 4-6 minutes following single administration.
Peak15.0 years to LOE
Product is at peak lifecycle stage as a critical care essential, suggesting stable team size with focus on operational excellence and cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on succinylcholine chloride positions you in a mission-critical essential medicine with stable, predictable demand in acute care and operating rooms globally. This is a career opportunity suited to professionals seeking operational mastery, supply chain excellence, and risk management rather than high-growth commercial dynamics or scientific innovation.
Brand Manager
Worked on SUCCINYLCHOLINE CHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.